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Abstract
Background The previous epidemiological surveys con-
ducted in Japan revealed that once the vicious cycle of
chronic musculoskeletal pain begins, it is difficult to dis-
rupt the cycle. This finding suggests the existence of
problems with the conventional approaches to treatment of
chronic musculoskeletal pain. The purpose of this study
was to investigate the characteristics of patients with
chronic musculoskeletal pain focusing on neuropathic and
psychogenic pain.
Methods The questionnaire was sent again to the 660
subjects found to have persistent chronic pain in the epi-
demiological surveys conducted in 2011. Responses were
collected from 588 subjects (response rate 90 %).
Results Of the 588 responders, 365 (62 %) complained of
persistent chronic pain. Among them, 128 (35 %) were still
receiving treatment and 193 (53 %) had discontinued
treatment. The degree of satisfaction with the treatment
was low, and 66 % of the patients had switched the med-
ical facility that they visited to receive treatment. The cited
reasons for the change in the medical facility visited and
discontinuation of treatment were ‘‘treatment was ineffec-
tive,’’ ‘‘I did not have sufficient time,’’ ‘‘I thought I could
take care of it myself,’’ and ‘‘Treatment seemed to be
unnecessary’’. Involvement of neuropathic pain was sug-
gested in 20 % of all the patients with chronic pain. As the
PainDETECT Score rose, the Visual Analog Scale (VAS)
score became higher and the change of medical facility for
treatment also increased. The Pain Catastrophizing Scale
score was correlated positively with the VAS score. The
Hospital Anxiety and Depression Scale score was signifi-
cantly correlated with the VAS score and the duration of
pain.
Discussion The results of this survey indicated that the
chronic course of musculoskeletal pain may be attributable
to the following factors: (1) lack of appropriate treatment
of neuropathic pain and psychogenic pain, and (2) insuf-
ficient awareness/knowledge among patients about chronic
musculoskeletal pain.
Introduction
The National Livelihood Survey provides data on symp-
toms currently prevalent in the Japanese general
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population. According to this survey, low back pain,
shoulder stiffness, joint pain and other types of pain are
highly ranked [1]. However, while attempting to devise
countermeasures against chronic pain among Japanese
people, we faced shortage of even basic information con-
cerning the types of pain. Taking this background into
account, we initiated the ‘‘longitudinal investigation of
chronic musculoskeletal pain’’ in 2010. Until date, we have
reported, based on the results of this survey, the prevalence
of chronic musculoskeletal pain (15.4 %), the frequency of
new onset of this type of pain (11.1 %), and the risk factors
for the onset of chronic pain in the Japanese population.
The investigation additionally revealed that chronic pain
was frequently persistent (45.2 %), and that the risk factors
for persistent pain were a VAS score of C7, duration of
pain of C5 years, and pain affecting the lower back. Of the
responders complaining of persistent chronic pain, more
than 80 % had a history of treatment; about 30 % were still
receiving treatment at the time of the investigation, while
50 % had discontinued treatment because of poor
satisfaction with the outcome of treatment [2, 3]. These
findings suggest that once the vicious cycle of chronic
musculoskeletal pain begins, it is difficult to disrupt the
cycle, and that the conventional approaches to treatment of
chronic musculoskeletal pain may involve problems. The
present survey was undertaken in the same subjects as
those in the previously performed mail-based survey to
characterize them with a chronic course of musculoskeletal
pain, with emphasis laid on the possible involvement of
neuropathic pain or psychogenic pain, and identification of
problems with the conventional approaches to treatment.
Methods
The questionnaire was mailed to 660 subjects who com-
plained of persistent chronic pain in both the epidemio-
logical surveys of 2010 and 2011 according to the mail-
based survey panel maintained by Nippon Research Center,
Ltd. [2, 3]. Responses were collected from 588 subjects
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(response rate, 90 %). The questionnaire used in this survey
contained questions to determine information on the basic
demographic characteristics of the subjects (gender, age,
location of living, occupation, etc.), information about the
chronic musculoskeletal pain (severity, location, duration,
presence/absence of treatment, treating medical facility,
therapeutic regimen used, treatment period, efficacy, degree
of satisfaction with treatment), and information about
neuropathic pain (PainDETECT score) [4] or psychogenic
pain (Hospital Anxiety and Depression scale: HADS, Pain
Catastrophizing Scale: PCS) [5, 6]. The subjects were
divided into three categories according to the PainDETECT
scores: the Non-neuropathic pain (NP) group (score of 12 or
less; low likelihood of involvement of neuropathic pain),
the Suspected NP group (score of 13–18; possible
involvement of neuropathic pain), and the NP group (score
of 19 or higher; strong suggestion of the involvement of
neuropathic pain). The HADS consisted of HADS-anxiety
(7 anxiety-related items: HADS-A) and HADS-depression
(7 depression-related items: HADS-D). The responders
were divided according to the HADS-A and HADS-D
scores (21 at the maximum each) into 3 categories: score of
7 or less (no problem), score of 8–10 (possible clinical
problems), and score of 11 or higher (evident clinical
problems). Responders with HADS-A/D scores of 10 or less
(non-anxiety group, non-depression group) and those with
HADS-A/D scores of 11 or higher (anxiety group, depres-
sion group) were compared. Chronic pain was defined as
pain experienced at least once in the past 30 days, with
severity of 5 or more on a visual analogue scale (VAS), and
persisting for 6 months or more, similar to the definition
adopted in the 2010 and 2011 surveys [2, 3]. Furthermore,
the age, gender, treatment period, frequency of change of
the treating facility, VAS score, PainDETECT score,
HADS score and PCS score in the responders with persis-
tent chronic pain were compared among medical facilities
and folk remedies. For inter-group comparison, t test or
ANOVA was used for continuous variables and the Chi-
square test or Fisher’s exact test for categorical variables.
This study was approved by the IRB of Keio University.
Results
Characteristics of the responders complaining
of persistent chronic pain
According to the definition of chronic pain, 365 (62 %) of
the 588 respondents had persistent chronic pain, while the
remaining 223 respondents (38 %) no longer complained
of chronic pain. A noteworthy finding was that the most
frequently recorded duration of pain was 10–15 years, and
the second most frequently recorded duration was
5–10 years (Fig. 1). The most frequently recorded site of
pain was the low back (75 %), followed by the neck and
shoulder (about 60 %), similar to the results of the previous
surveys (Fig. 2a). When individual respondents were
questioned about the site of the most persistent pain, the
most frequent response was the lower back (33 %), fol-
lowed by the neck and shoulder (Fig. 2b).
Treatment status among responders complaining
of persistent chronic pain
Of the 365 responders complaining of persistent chronic
pain, 128 (35 %) were still receiving treatment at the time
of the survey, while 193 (53 %) had discontinued treat-
ment. Forty-four responders (12 %) were not receiving
treatment despite the presence of persistent pain (Fig. 3a).
The treatment period was 1 year or longer in about 40 % of
all respondents, indicating a tendency for prolonged treat-
ment (Fig. 3b). When questioned about the outcome of
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treatment at the first treating facility, the responses were
‘‘disappeared, improved or slightly improved’’ in 57 %,
and ‘‘unchanged, slightly aggravated or aggravated’’ in
39 % (Fig. 3c). The degree of satisfaction with treatment
was ‘‘very satisfied or slightly satisfied’’ in only 29 %, and
‘‘neutral, slightly unsatisfied or very unsatisfied’’ in as
many as 69 % of the cases (Fig. 3d).
As a result, the responders often changed the treating
facility (66 %), with the frequency of change being once in
40 %, twice in 3 %, three times in 11 %, and 4 times or more
in 18 % of the cases (Fig. 4a, b). In a further analysis of the
changes in the treating facility, the type of facility providing
the initial treatment was most frequently orthopedics (185
responders, 58 %), followed in frequency by a chiropractic/
osteopathy (82 responders, 26 %). However, when asked
about the type of facility visited as the second treating
facility, a smaller number of responders answered ‘‘ortho-
pedics’’ (84 responders) and a larger number of responders
answered ‘‘chiropractic/osteopathy’’ (87 responders), with
scarce change in the number of responders answering
‘‘massage/acupuncture.’’ When asked about the type of
facility visited as the third and subsequent treating facility,
the number of responses for each type of facility decreased to
a similar degree (Fig. 4c).
The most frequent reason for changing the treating
facility was ‘‘treatment was ineffective’’ (35 %), followed
by ‘‘I did not have sufficient time’’ (30 %), ‘‘I thought I
could take care of it myself’’ (10 %), and ‘‘it was eco-
nomically unaffordable’’ (10 %) (Fig. 5a). The reason for
not receiving any treatment was ‘‘efficacy was not
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expected’’ (29 %), ‘‘I thought it may be possible to deal
with the pain by myself’’ (27 %), ‘‘I wanted to receive
treatment, but could not receive it’’ (18 %), and ‘‘treatment
seemed to be unnecessary’’ (11 %) (Fig. 5b).
Involvement of neuropathic pain in persistent chronic
pain
Involvement of neuropathic pain in the responders com-
plaining of persistent chronic pain was investigated through
analysis of the PainDETECT scores. The percentage of
responders classified into the NP group was 7 %, and that of
responders classified into the Suspect NP group was 13 %
(Fig. 6a). In an analysis of the relation to gender, involve-
ment of neuropathic pain was seen more frequently in males
than in females with a marginal significance (p = 0.06)
(Fig. 6b). In the analysis of the relationship between the VAS
score and PainDETECT score, the VAS scores differed
significantly among the three groups divided according to the
involvement of neuropathic pain. There were significant
differences in VAS scores between the non-NP and Suspect-
NP groups (p = 0.043), and between the non-NP and NP
groups (p \ 0.001, Bonferroni post-hoc test) (Fig. 6c).
There was a significant difference in the frequency of change
of the treating facility among the three groups (p \ 0.05).
Even after removing the influence of VAS score, covariance
analysis revealed that the frequency of change of the treating
facility was lower in the non-NP group compared to the NP
group with a marginal significance (p = 0.056) (Fig. 6d).
Involvement of psychogenic pain in persistent chronic
pain
The involvement of psychological factors in chronic mus-
culoskeletal pain was investigated through analysis of the
correlation between the VAS scores and PCS scores. This
-
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analysis revealed a weak but statistically significant positive
correlation between the VAS and PCS scores (Spearman’s
correlation coefficient = 0.224, p \ 0.001) (Fig. 7a). When
analyzed in relation to the HADS-A score, the VAS score
was significantly higher in the responders classified into the
anxiety group than in the responders classified into the non-
anxiety group, while the duration of pain did not differ sig-
nificantly between the two groups. When analyzed in relation
to the HAD-D score, the duration of pain was significantly
longer in the depression group than in the non-depression
group (p = 0.019, covariance analysis with VAS score),
while the VAS score did not differ significantly between the
two groups (Fig. 7b).
Characteristics of the responders complaining
of persistent chronic pain, analyzed by the type
of the first treating facility
The characteristics of the responders complaining of per-
sistent chronic pain were compared between the two
groups divided by the type of the first treating facility, i.e.,
the group which received the first treatment at a medical
facility (medical facility group) and the group which
received the first treatment at a folk remedy (folk remedy
group). The male-to-female ratio did not differ significantly
between the medical facility group and the folk remedy
group, however, the age of the responders was significantly
higher in the medical facility group than in the folk remedy
group. There was no significant difference in terms of the
treatment period or the frequency of change of the treating
facility between the two groups. The VAS score did not
differ between the two groups either. The PainDETECT
score tended to be higher in the medical facility group (8.3)
than in the folk remedy group (6.4), although the difference
was not statistically significant (p = 0.06). The PCS score
was significantly higher in the medical facility group (26.5)
than in the folk remedy group (23.2) (p \ 0.01, Table 1).
Discussion
Current status of responders complaining of persistent
chronic musculoskeletal pain
Of the responders who complained of chronic musculo-
skeletal pain at the time of the survey in 2010, 45 %
continued to complain of chronic pain in the 2011 survey,
and the percentage of responders still complaining of
chronic pain rose to 62 % in the survey of 2012. This result
suggests that relief from chronic musculoskeletal pain
becomes more difficult as the duration of chronic pain
increases. In the present survey, the mean VAS score was
higher than the score recorded in the 2010 survey, and the
most frequent site of pain was the low back (70 %), sug-
gesting the possibility that many of the responders com-
plaining of chronic pain in this survey had intractable low
back pain. This finding is consistent with the results of the
longitudinal epidemiological survey of 2011, in which the
pain in the ‘‘low back’’ as the site of pain and pain for
‘‘5 years or longer’’ as the duration of pain were suggested
as risk factors for the persistence of chronic pain [3]. Past
reports have also suggested that lower back pain is asso-
ciated with a high risk of relapse and a chronic course [7–
11]. Therefore, approaches for dealing with the high-risk
group will become more important when countermeasures
against chronic musculoskeletal pain are discussed.
Problems with treatment of persistent chronic pain
and countermeasures
Slightly more than 80 % of all responders complaining of
persistent chronic pain had a history of treatment, with the
treatment still continuing in 30 % of the respondents at the
a
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time of the present survey. The remaining 50 % were no
longer receiving treatment despite persistent pain. When
asked about the efficacy of treatment, about 40 % answered
‘‘unchanged’’ or ‘‘aggravated,’’ with the degree of satis-
faction with the treatment being ‘‘neutral,’’ ‘‘slightly
unsatisfied’’ or ‘‘quite unsatisfied’’ in about 70 %. This
tendency was similar to that seen in the 2011 survey. Thus,
66 % of respondents complaining of chronic pain changed
the treating facility, with the frequency of change being
once or twice in about 70 % of the responders who chan-
ged the treating facility. To our surprise, 30 % of the
responders changed their treating facility three or more
times, suggesting that the percentage of responders
engaging in so-called ‘‘doctor shopping’’ cannot be
ignored. When changes in the type of the treating facility
were analyzed, the first treating facility was an orthopedics
in slightly more than 60 % of all responders, while the
share of orthopedics as the treating facility decreased to
about 50 % after the first change of the treating facility.
There was, however, no marked change in the share of folk
remedies as the treating facility. This result is consistent
with the finding from the survey of 2011, which revealed
that the degree of satisfaction with treatment at medical
facilities was lower than that at folk remedies [3], sug-
gesting that the initial treatment provided at medical
facilities may not be adequate. However, there was no
marked difference between medical facilities and folk
remedies in terms of the tendency towards subsequent
changes of the treating facility. The most frequent reason
for changing the treating facility or discontinuing treatment
was ‘‘treatment was ineffective,’’ indicating that the current
approach for treating chronic musculoskeletal pain may not
be sufficiently effective. To identify the factors possibly
underlying this finding, we investigated the involvement of
neuropathic pain and psychogenic pain in persistent
chronic musculoskeletal pain.
This analysis suggested possible involvement of neuro-
pathic pain in about 20 % of all responders complaining of
chronic pain. It was additionally revealed that the VAS
score rose significantly and the frequency of change of the
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treating facility also increased as the likelihood of
involvement of neuropathic pain became higher. Regarding
psychogenic pain, a significant positive correlation was
noted between PCS and VAS scores, an increase in HADS-
A score was associated with an increase of the VAS score,
and an increase in the HADS-D score was associated with a
longer duration of pain. In regard to chronic low back pain,
which was the most frequent type of pain recorded in the
present survey, the previously reported important role of
psychogenic factors [12–16] was also endorsed by the
results of the present survey. Interestingly enough, analysis
of the characteristics of the responders complaining of
chronic pain in relation to the type of the first treating
facility revealed that medical facilities more frequently
managed patients of advanced age and with a stronger
likelihood of involvement of neuropathic pain and psy-
chogenic pain than folk remedies. These factors may
explain, at least partially, the relatively low satisfaction
level of responders with the treatment at medical facilities.
However, caution is needed while interpreting the results as
to psychogenic pain, in view of the possibility that treat-
ment may result in progression of catastrophic thinking or
depressive mood.
Taken together, these results suggest that many of the
patients complaining of chronic musculoskeletal pain
seek treatment at the orthopedic clinic/department first,
but tend to show low levels of satisfaction with the
treatment because of insufficient efficacy, and that neu-
ropathic pain and psychogenic pain may be involved in
the poor responses of these patients to treatment. Lack of
adequate assessment for neuropathic and psychogenic
pain during the initial treatment of chronic
Table 1 Characteristics of the responders with chronic pain, ana-
lyzed by the type of the first treating facility
Medical
facility
(n = 213)
Folk
remedy
(n = 108)
p value*
Sex
Female Number
(column
%)
129 (60.3) 75 (69.4) 0.11
Male 85 (39.7) 33 (30.6)
Age Average
(SD)
54.8 (14.8) 46.2
(13.8)
\0.01
Duration of
treatment (years)
Average
(SD)
10.3(9.0) 10.4 (7.2) 0.91
Frequency of
change in the
treatment facility
Number
(column
%)
1 77 (36.0) 34 (31.5) 0.65
2 51 (23.8) 33 (30.6)
3 43 (20.1) 22 (20.4)
4 18 ( 8.4) 6 (5.6)
5 or more 25 (11.7) 13 (12.0)
VAS Average
(SD)
6.1 (1.1) 6.4 (1.1) 0.13
PainDETECT
score
Average
(SD)
8.3 (6.7) 6.8 (5.9) 0.06
PainDETECT
12 or less Number
(column
%)
146 (76.4) 86 (83.5) 0.34
13–18 29 (15.2) 12 (11.7)
19 or more 16 ( 8.4) 5 (4.9)
PCS score Average
(SD)
26.5 (10.3) 23.2 (9.9) \0.01
* t test, v2 test, Fisher’s exact
Spearman’s correlation 
coefficient = 0.224
(p < 0.001)
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musculoskeletal pain and the resultant absence of
appropriate treatment seem to lead to ‘‘doctor shopping’’
by patients. A past report also pointed out the close
involvement of neuropathic pain with chronic low back
pain [17]. To resolve this issue, it will be important to
assess the involvement of neuropathic pain on the basis
of the PainDETECT score and neuropathic severity score
before treatment is started in individual patients com-
plaining of chronic musculoskeletal pain. Furthermore,
the results of the present survey suggest that if treatment
is provided in a manner tailored to the status of
involvement of psychogenic pain rated by the HADS and
PCS, it may become possible to reduce the intensity of
pain and shorten the duration of pain.
Many previous reports have shown that chronic mus-
culoskeletal pain can impair not only physical health, but
also mental health, which may have a large impact on the
daily living and social activities of the patients [2, 18].
However, the awareness among patients about chronic pain
does not seem to be sufficient, considering the finding from
this survey that patients often decided to discontinue
treatment or seek no treatment for chronic pain persisting
for 3 years or more, on grounds such as ‘‘I did not have
sufficient time,’’ ‘‘I thought I could take care of it myself’’
and ‘‘I thought treatment was unnecessary.’’ At present, the
actual status of chronic musculoskeletal pain is not suffi-
ciently well understood by the people in Japan. Dissemi-
nation of information through various media to deepen the
understanding of the people is important for ensuring a
sufficient level of awareness among the people of Japan
about the significance of chronic musculoskeletal pain
treatment.
This study was conducted as a 2011 Ministry of Health,
Labour and Welfare: Health Labour Sciences Research
Grant for Comprehensive Research on Disability Health
and Welfare (Survey study of chronic musculoskeletal
pain).
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